Skip to main content
. 2019 Jan 28;35(1):231–239. doi: 10.3904/kjim.2018.137

Figure 3.

Figure 3.

Changes in distribution of simplified disease activity index (SDAI) in conventional disease-modifying antirheumatic drug (cDMARD) or biologic DMARD (bDMARD) groups at 6 and 12 months. Depicted numbers are percentages of patients.